Association of MIR-499a expression and seed region variant (rs3746444) with cardiovascular disease in Egyptian patients

References

• Anderson JL, Adams CD, Antman EM, et al. ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e179–e347.
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835–840.
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stressresponsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255–18260.
   PubMed Web of Science ®Google Scholar
• Tijsen AJ, Pinto YM, Creemers EE. Non-cardiomyocyte microRNAs in Heart Failure. Cardiovasc Res. 2012;93:573–582.
   Web of Science ®Google Scholar
• Williams AH, Liu N, van Rooij E, et al. MicroRNA control of muscle development and disease. Curr Opin Cell Biol. 2009;21:461–469.
   PubMed Web of Science ®Google Scholar
• Haider BA, Baras AS, McCall MN, et al. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One. 2014;9:e89565.
   PubMed Web of Science ®Google Scholar
• Corsten MF, Dennert R, Jochems S, et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010;3:499–506.
   Web of Science ®Google Scholar
• Gu YL, Voors AA, Zijlstra F, et al. Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol. 2011;100:1069–1076.
   PubMed Web of Science ®Google Scholar
• Agewall S, Giannitsis E, Jernberg T, et al. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32:404–411.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen L, Chen D, et al. Influence of microRNA-related polymorphisms on clinical outcomes in coronary artery disease. Am J Transl Res. 2015;7:393–400.
   Web of Science ®Google Scholar
• Toraih EA, Ismail NM, Toraih AA, et al. Precursor miR-499a variant but not miR-196a2 is associated with rheumatoid arthritis susceptibility in an Egyptian population. Mol Diagn Ther. 2016;20:279–295.
   PubMed Web of Science ®Google Scholar
• Zhi H, Wang L, Ma G, et al. Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin Res Cardiol. 2012;101:289–296.
   PubMed Web of Science ®Google Scholar
• Chen C, Hong H, Chen L, et al. Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population. Tohoku J Exp Med. 2014;233:89–94.
   Web of Science ®Google Scholar
• Devaux Y, Vausort M, Goretti E, et al. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem. 2012;58:559–567.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020–2035.
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004 Aug. Available from: https://www.ncbi.nlm.nih.gov/books/NBK9630/
   Google Scholar
• Prineas R, Crow R, Blackburn H. The Minnesota code manual of electrocardiographic findings. Littleton (MA): John Wright-PSG, Inc.; 1982.
   Google Scholar
• Medina R, Panidis IP, Morganroth J, et al. The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with or without a dilated left ventricle. Am Heart J. 1985;109:799–803.
   Web of Science ®Google Scholar
• Lipinski M, Do D, Morise A, et al. What percent luminal stenosis should be used to define angiographic coronary artery disease for noninvasive test evaluation? Ann Noninv Electrocard. 2002;7:98–105.
   Web of Science ®Google Scholar
• World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO Consultation. Geneva: World Health Organization; 2006.
   Google Scholar
• Kamal HM, Ahmed AS, Fawzy MS, et al. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients. Acta Cardiol. 2011;66:483–488.
   Web of Science ®Google Scholar
• Cui J, Zhao N. Consideration in selection of the control group in diagnostic tests. Int J Biol Sci. 2012;8:1418–1419.
   Web of Science ®Google Scholar
• Toraih EA, Mohammed EA, Farrag S, et al. Pilot study of serum microRNA-21 as a diagnostic and prognostic biomarker in Egyptian breast cancer patients. Mol Diagn Ther. 2015;19:179–190.
   PubMed Web of Science ®Google Scholar
• Sala V, Bergerone S, Gatti S, et al. MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. Cell Mol Life Sci. 2014;71:1439–1452.
   Web of Science ®Google Scholar
• Vickers KC, Rye KA, Tabet F. MicroRNAs in the onset and development of cardiovascular disease. Clin Sci. 2014;126:183–194.
   Web of Science ®Google Scholar
• Jia Z, Wang J, Shi Q, et al. SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition. Apoptosis. 2016;21:174–183.
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255–18260.
   PubMed Web of Science ®Google Scholar
• Wang J, Jia Z, Zhang C, et al. miR-499 protects cardiomyocytes from H2O2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol. 2014;11:339–350.
   PubMed Web of Science ®Google Scholar
• Wilson KD, Hu S, Venkatasubrahmanyam S, et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet. 2010;3:426–435.
   Google Scholar
• Shieh JT, Huang Y, Gilmore J, et al. Elevated miR-499 levels blunt the cardiac stress response. PLoS One. 2011;6:e19481.
   Web of Science ®Google Scholar
• Adachi T, Nakanishi M, Otsuka Y, et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem. 2010;56:1183–1185.
   PubMed Web of Science ®Google Scholar
• Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31:659–666.
   PubMed Web of Science ®Google Scholar
• Yao Y, Du J, Cao X, et al. Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients. PLoS One. 2014;9:e104618.
   PubMed Web of Science ®Google Scholar
• Cheng C, Wang Q, You W, et al. MiRNAs as biomarkers of myocardial infarction: a meta-analysis. PLoS One. 2014;9:e88566.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011;124:175–184.
   PubMed Web of Science ®Google Scholar
• Sluijter JPG, van Mil A, van Vliet P, et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol. 2010;30:859–868.
   PubMed Web of Science ®Google Scholar
• Wang JX, Jiao JQ, Li Q, et al. miR-499 regulates mitochondrial dynMIcs by targeting calcineurin and dynMIn-related protein-1. Nat Med. 2011;17:71–78.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Eskandari-Nasab E, Zakeri Z, et al. Association of pre-miRNA-146a rs2910164 and pre-miRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis. Mol Med Rep. 2013;7:287–291.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma Y, Zhang B, et al. Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population. J Mol Neurosci. 2014;52:473–480.
   Web of Science ®Google Scholar
• Xiong XD, Cho M, Cai XP, et al. A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res. 2014;761:15–20.
   PubMed Web of Science ®Google Scholar